Source:http://linkedlifedata.com/resource/pubmed/id/16099598
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2005-10-28
|
| pubmed:abstractText |
Total-abdominal hysterectomy and bilateral salpingo-oophorectomy (TAHBSO) is the gold-standard therapy for patients with endometrial carcinoma. However, patients with high operative risks are usually treated with radiation therapy (RT) alone. The goal of this study was to update our experience of high-dose-rate brachytherapy (HDRB), with or without external-beam irradiation (EBRT), for such patients.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0360-3016
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
63
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1108-13
|
| pubmed:meshHeading |
pubmed-meshheading:16099598-Adenocarcinoma,
pubmed-meshheading:16099598-Aged,
pubmed-meshheading:16099598-Aged, 80 and over,
pubmed-meshheading:16099598-Brachytherapy,
pubmed-meshheading:16099598-Endometrial Neoplasms,
pubmed-meshheading:16099598-Female,
pubmed-meshheading:16099598-Humans,
pubmed-meshheading:16099598-Middle Aged,
pubmed-meshheading:16099598-Radiotherapy Dosage,
pubmed-meshheading:16099598-Survival Analysis
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma.
|
| pubmed:affiliation |
Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada.
|
| pubmed:publicationType |
Journal Article
|